Cargando…
Luteolin protects DYT-PRKRA cells from apoptosis by suppressing PKR activation
DYT-PRKRA is a movement disorder caused by mutations in the PRKRA gene, which encodes for PACT, the protein activator of interferon-induced, double-stranded RNA (dsRNA)-activated protein kinase PKR. PACT brings about PKR’s catalytic activation by a direct binding in response to stress signals and ac...
Autores principales: | Frederick, Kenneth, Patel, Rekha C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974672/ https://www.ncbi.nlm.nih.gov/pubmed/36874028 http://dx.doi.org/10.3389/fphar.2023.1118725 |
Ejemplares similares
-
DYT-PRKRA Mutation P222L Enhances PACT’s Stimulatory Activity on Type I Interferon Induction
por: Vaughn, Lauren S., et al.
Publicado: (2022) -
DICER1 and PRKRA in Colon Adenocarcinoma
por: Chiosea, S., et al.
Publicado: (2008) -
Luteolin Alleviates Methamphetamine-Induced Hepatotoxicity by Suppressing the p53 Pathway-Mediated Apoptosis, Autophagy, and Inflammation in Rats
por: Zhang, Kai-Kai, et al.
Publicado: (2021) -
The Protective Effect of Luteolin in Glucocorticoid-Induced Osteonecrosis of the Femoral Head
por: Yan, Zijian, et al.
Publicado: (2020) -
PACT/PRKRA and p53 regulate transcriptional activity of
DMRT1
por: Fujitani, Kazuko, et al.
Publicado: (2020)